CCAP Stock Analysis: Buy, Sell, or Hold?

CCAP - Crescent Capital BDC, Inc. Common stock

$14.39
0.04 (0.28%) β–²
BUY
MODERATE Confidence
Last Updated: January 30, 2026
Earnings: Feb 18, 2026 17d

Get Alerted When CCAP Hits Your Target Price

Join 10,000+ traders who never miss a move

You're in! Check your email to confirm and set your target price.
100% Free No spam, ever Unsubscribe anytime

Interactive Price Chart (1 Month)

Loading chart...

Loading historical data...

πŸ’‘
Bottom Line:
πŸ’‘ BUY OPPORTUNITY: CCAP shows positive signals but monitor for confirmation. Market pricing in 0.2% decline. Moderate conviction.

Long-Term Wealth Forecast (2031)

Based on Analyst Consensus Growth & Historical Valuation

0% (Stagnation) 50% (Hyper Growth)
EST. PRICE IN 2031
$12.09
Based on -3.5% avg growth
INTRINSIC VALUE TODAY
$7.51
Trading above fair value

How this is calculated: We use a Growth Decay Model: starting with analyst consensus growth (adjusted above) and gradually slowing it down to a long-term terminal rate (4%) by Year 5. This provides a more realistic valuation than assuming constant hyper-growth. We then apply a 9.1x Exit PE.

In-depth Analysis How we analyze

Valuation Analysis: CCAP is currently trading at $14.39, which is considered fair relative to its 30-day fair value range of $14.27 to $14.64. The stock's valuation (Forward PE: 9.0) is in line with its historical norms (9.1). Remarkably, the market is currently pricing in an annual earnings decline of 0.2% over the next few years. This aligns with recent fundamental challenges.

Technical Outlook: Technically, CCAP is showing sideways momentum. The price is currently testing key support at $14.16. A bounce from this level would confirm strength, while a break below could signal further downside.

Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Combining these factors, the current setup offers a favorable risk/reward ratio for buyers.

Quick Decision Summary

Current Position FAIR
Fair Price Range $14.27 - $14.64
Company Quality Score 57/100 (HOLD)
Options IV Signal 50th percentile (NORMAL)
Volume Confirmation HIGH
Confidence Score 68.1%

All Signals

  • NEUTRAL: Price in fair range
  • NEUTRAL: Options fairly priced (IV 50th percentile)
  • NEUTRAL: Mixed technical signals (40/100)
  • BULLISH: High volume confirmation
  • NEUTRAL: Near Wall St target ($15.75)

Fair Price Analysis

30-Day Fair Range $14.27 - $14.64
Current vs Fair Value FAIR
Expected Move (7 Days) Β±$1.42 (9.9%)

Support & Resistance Levels

Support Level $14.16
Resistance Level $14.85
Current Trend Sideways

Fundamental Context

Forward P/E (Next Year Est.) 9.00
Wall Street Target $15.75 (+9.8%)
Revenue Growth (YoY) -19.9%
Earnings Growth (YoY) -53.5%
Profit Margin 20.8%
Valuation Discount vs History -0.2% cheaper
PE vs Historical 9.0 vs 9.1 FAIR
Market-Implied Price Targets If current PE multiple persists
Implied Growth (YoY): -0.2% (market-implied from PE analysis)
1-Year Target $14.32 (0%)
2-Year Target $14.29 (0%)
3-Year Target $14.26 (-1%)
3-Yr Target (if PE normalizes) (PE: 9β†’9) $14.43 (+1%)
3-Year Scenarios Using analyst projected EPS growth
Bull: (PE: 22.3, Growth: -10.9%) $25.93 (+81%)
Base: (SPY PE: 9.0, Growth: -10.9%) $10.46 (-27%)
Bear: (PE: 7.6, Growth: -10.9%) $8.89 (-38%)
πŸ“ˆ Valuation based on Current Earnings
RECOVERY PLAY: Stock looks expensive now (15x PE), but valuation improves significantly next year (9x PE) as earnings recover.
Trailing PE: 14.62 | Current EPS (TTM): $0.97
Bull Case $25.65 (+78%)
Analyst growth 64.4%, PE expands to 16.1
Base Case $23.32 (+62%)
Market implied 64.4%, PE stable at 14.6
Bear Case $9.64 (-33%)
Severe decline -20.0%, PE contracts to 12.4
These are projections based on PE multiples and EPS growth scenarios, not predictions. Actual results may vary significantly.
πŸ’‘ Upside Surprise Potential
If earnings stabilize (0% growth), PE could expand from 9.0 to 9.1
Stabilization Target: $14.51 (+1.1%)
PE Expansion Potential: +1.1%
Last updated: January 30, 2026 10:52 PM ET
Data refreshes hourly during market hours. Next update: 11:52 PM
πŸ”₯ Top Stocks Breaking Out Now
Ticker Score Recommendation Change %
Insider Activity (6 Months)
2
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Kirill Bouek BUY 200 shares 2025-08-28
Raymond Barrios BUY 3245 shares 2025-08-25

Top Rated Asset Management Stocks

Top-rated stocks in Asset Management by analyst ratings.

Stock Analyst Consensus Analyst Target Tradestie Score
BLK
BlackRock Inc
STRONG BUY
17 analysts
$1334 59 HOLD
HASI
Hannon Armstrong Sustain…
STRONG BUY
16 analysts
$40 63 BUY
APO
Apollo Global Management…
STRONG BUY
19 analysts
$165 56 HOLD
CRBG
Corebridge Financial Inc.
STRONG BUY
14 analysts
$38 66 BUY
BX
Blackstone Group Inc
HOLD
23 analysts
$178 52 HOLD

Advanced CCAP Option Strategies

Professional options setups generated by AI based on today's CCAP price and gamma walls.

Iron Condor Bull Call Bear Put Collar

More Analysis for CCAP

CCAP Technical Chart CCAP Price Prediction CCAP Earnings Date CCAP Investment Advisor CCAP Fair Price Analyzer CCAP Options Advisor CCAP Options Chain CCAP Options Analysis
Live Trades
From trading groups
Loading trades...
View All Live Trades See Trader Consensus & Signals